Abstract
These adverse drug events, also known as ADEs, are a major cause for concern in the healthcare industry since they are a contributor to morbidity, mortality, and increased healthcare expenditures. Community pharmacies, which serve as the primary point of contact for a large number of patients, play an essential part in the process of identifying and preventing adverse drug reactions (ADEs). The implementation of technology in these contexts presents a number of interesting options that have the potential to improve patient safety and drug management capabilities. Within the context of community pharmacy, this research investigates the impact that various technological improvements have had on the prevention and monitoring of adverse drug reactions (ADEs). Telepharmacy, clinical decision support systems (CDSS), automated dispensing systems, and electronic health records (EHRs) are some of the key technologies that are mentioned. Through this analysis, the benefits, challenges, and future directions of technology-driven pharmacovigilance in community pharmacies are highlighted. Additionally, the review emphasises the necessity of continuous innovation and adaptation in order to enhance patient outcomes and the efficiency of healthcare.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.